PlainRecalls
FDA Devices Low Class III Terminated

ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.

Reported: May 13, 2020 Initiated: April 1, 2020 #Z-1893-2020

Product Description

ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.

Reason for Recall

Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.

Details

Recalling Firm
Abbott Laboratories
Units Affected
65 kits total
Distribution
International distributed only in Mexico, no US distribution.
Location
Abbott Park, IL

Frequently Asked Questions

What product was recalled?
ARCHITECT C Peptide Reagent - Product Usage: used as an aid in the diagnosis and treatment of patients with abnormal insulin secretion including diabetes mellitus.. Recalled by Abbott Laboratories. Units affected: 65 kits total.
Why was this product recalled?
Error in the renewal documentation process for license in Mexico. All in date ARCHITECT C Peptide Reagents, Calibrators and Controls are being recalled until a new license is obtained.
Which agency issued this recall?
This recall was issued by the FDA Devices on May 13, 2020. Severity: Low. Recall number: Z-1893-2020.